STEPHANIE AVERETTE: Open Payments
NPI 1124113170 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 4 payments from 4 companies in 2025. Trend: 2023 $1,742 · 2024 $791 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $107 |
| Vanda Pharmaceuticals Inc. | 1 | $101 |
| Neurocrine BioSciences, Inc. | 1 | $88 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $85 |
Products named: LYBALVI, FANAPT, INGREZZA.
Industry payments across SC — which companies pay providers there.
